Skip to main content

Edwards Lifesciences Corp total debt

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.47B

Edwards Lifesciences Corp's total debt was $705 million for fiscal year 2025 (the twelve months to 31 Dec 2025), up 0.8% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was $705 million, up 0.6% from a year earlier.

From Edwards Lifesciences Corp's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.

Fiscal 2025
$705M
+0.8%
Q3 FY2026
$705M
+0.6% on a year
Growth over 9 years
−1.7%
a year, FY 2016–FY 2025

Total debt by fiscal year

$822MFY 2016$1.04BFY 2017+26.0%$594MFY 2018−42.7%$679MFY 2019+14.3%$695MFY 2020+2.4%$690MFY 2021−0.7%$691MFY 2022+0.1%$685MFY 2023−0.9%$700MFY 2024+2.2%$705MFY 2025+0.8%

Change on the year before, under each year. From FY 2016 to FY 2025, Edwards Lifesciences Corp's total debt went from $822 million to $705 million, a compound annual change of −1.7%; the highest was $1.04 billion in FY 2017.

Edwards Lifesciences Corp total debt, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Total debt$822M$1.04B$594M$679M$695M$690M$691M$685M$700M$705M
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Total debt by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Edwards Lifesciences Corp total debt, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Total debt$700M$699M$703M$700M$705M$703M$704M$705M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How total debt is measured

Total debt is the company's borrowings at the end of the period: short-term and long-term debt, including the current portion of long-term debt and finance leases. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Edwards Lifesciences Corp's other figures

Total debt of comparable companies

Everything on EW, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.